The ROC curve showed that the area under the curve was 0.821, (95% CI 0.642–0.999), indicating that it yielded a high predictive value for using a pre-treatment plasma concentration of CNP to predict the efficacy of oral metoprolol therapy in patients with POTS. The gene discussed is CNP; the disease is postural orthostatic tachycardia syndrome.